Elevation of low-density lipoprotein cholesterol concentration with over-the-counter fish oil supplementation

Annals of Pharmacotherapy

Volumn 41, Issue 7-8, 2007, Pages 1296-1300

  Malinowski, Jennifer M ^a,b   Metka, Kimberly ^a,c  

^a WILKES UNIVERSITY   (United States)

^b GEISINGER HEALTH SYSTEM   (United States)

^c YORK HOSPITAL   (United States)

Author keywords

Fish oil; Low density lipoprotein cholesterol; Omega 3 fatty acids; Triglycerides

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; NON PRESCRIPTION DRUG; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CASE REPORT; DIET SUPPLEMENTATION; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LIVER CELL; NARANJO PROBABILITY SCALE; PATIENT MONITORING; PRIORITY JOURNAL; RATING SCALE; RECEPTOR DOWN REGULATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; DRUGS, NON-PRESCRIPTION; FEMALE; FISH OILS; HUMANS; HYPERCHOLESTEROLEMIA; MIDDLE AGED;

EID: 34547180785     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H695     Document Type: Article

References (26)

1. Sinclair HM. Deficiency of essential fatty acids and atherosclerosis, et cetera. Lancet 1956;i:381-3.
2. Bang HO, Dyerberg J, Nielsen AB. Plasma lipid and lipoprotein pattern in Greenlandic west-coast Eskimos. Lancet 1971;1:1143-5.
3. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205-9.
4. Kromhout D, Feskens EJ, Bowles CH. The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population. Int J Epidemiol 1995;24:340-5.
5. Shekelle RB, Missell L, Paul O, et al. Fish consumption and mortality from coronary heart disease (letter). N Engl J Med 1985;313:820.
6. Dolecek TA, Granditis G. Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet 1991;66:205-16.
7. Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997;336:1046-53.
8. Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA 1998;279:23-8.
9. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989;2:757-61.
10. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Soprawivenza nell'Infarto miocardico. Lancet 1999;354:447-55.
11. Burr ML, Sweetham PM, Fehily AM. Diet and reinfarction. Eur Heart J 1994;15:1152-3.
12. Dolecek TA. Epidemiologic evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial. Proc Soc Exp Biol Med 1992;200:177-82.
13. Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomized open-label, blinded endpoint analysis. Lancet 2007;369:1090-8.
14. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747-57.
15. Harris WS. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997;65(5 suppl):1645S-54S.
16. NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Reports of the National Cholesterol Educations Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation 2002;106:3143-421.
17. Product information. Omacor (omega-3-acid ethyl esters). Liberty Corner, NJ: Reliant Pharmaceuticals, April 2005.
18. Fish oil. Natural Medicines Comprehensive Database. www.naturaldatabase. com (accessed 2007 Apr 19).
19. DeFilippis A, Sperling L. Understanding omega-3's. Am Heart J 2006;151:564-70.
20. Nestel PJ. Fish oil and cardiovascular disease: lipids and arterial function (abstract). Am J Clin Nutr 2000;71:228S-31S.
21. Westphal S, Orth M, Ambrosch A, et al. Postprandial chylomicrons VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids. Am J Clin Nutr 2000;71:914-20.
22. Sorensen NS, Markmann P, Hoy C-E, can Duyvenvoorde W, Princen HMG. Effect of fish oil enriched margarine on plasma lipids, low density lipoproteins particle composition, size and susceptibility to oxidation. Am J Clin Nutr 1998;68:235-41.
23. Suzukawa M, Abbey M, Howe PRC, Nestel PJ. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability and uptake by macrophages. J Lipid Res 1995;36:473-84.
24. Whitman SC, Fish JR, Rand ML, Rogers KA. n-3 Fatty acid incorporation into LDL particles renders them more susceptible to oxidation in vitro but not necessarily more atherogenic in vivo. Arterioscler Thromb 1994; 14:1170-6.
25. Suzukawa M, Abbey M, Clifton P, Nestel PJ. Enhanced capacity of n-3 fatty acid enriched macrophages to oxidize low density lipoprotein mechanisms and effects of antioxidant vitamins. Atherosclerosis 1996;124:157-69.
26. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.